9 recruiting, 7 completed, 3 unknown, 2 active not recruiting. 6 Phase 2, 3 Not applicable, 2 Phase 1, 1 Early Phase 1, 1 Phase 3.
Follow Pancreatectomy: new trials by email Literature Review of Pancreatectomy trials Research Report on Pancreatectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors Pancreatectomy, Quality-of-Life Assessment, Treatment Planning - Benign Pancreatic Neoplasm, Chronic Pancreatitis | Phase 1 / Phase 2 | Not yet recruiting | OHSU Knight Cancer Institute | 12 | 2026-07-01 | 2025-11-25 |
| To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement. Pancreatectomy, Complete Cytoreduction, Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - Pancreatic Adenocarcinoma, Peritoneal (Metastatic) Cancer | Not applicable | Recruiting | Unidade Local de Saúde São João, Oporto | 20 | 2026-03-01 | 2026-03-25 |
| A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer Chemotherapy, Radiology, Pancreatectomy - Locally Advanced Pancreatic Cancer, Borderline Resectable Pancreatic Cancer | Recruiting | Oslo University Hospital | 400 | 2024-12-03 | 2025-04-25 | |
| Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma pancreatectomy - Pancreatic Cancer | Not applicable | Completed | University Hospital, Rouen | 40 | 2024-05-28 | 2026-02-06 |
| Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer Arm I Packed Red Blood Cell Transfusion (Hgb < 7 g/dL), Arm II Packed Red Blood Cell Transfusion (Hgb < 9 g/dL), Computed Tomography - Resectable Pancreatic Carcinoma | Early Phase 1 | Terminated | Jonsson Comprehensive Cancer Center | 1 | 2023-08-10 | 2025-06-10 |
| Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety Pancreatectomy - Pancreatectomy, Hyperamylasemia | Recruiting | Technische Universität Dresden | 150 | 2023-07-18 | 2026-08-27 | |
| Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer Biopsy, FOLFIRINOX, Ciprofloxacin - Pancreatic Cancer | Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 25 | 2023-03-16 | 2024-10-15 |
| Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases Pancreatectomy and liver resection, Chemotherapy - Pancreas Neoplasms, Liver Metastasis | Completed | Azienda Ospedaliero-Universitaria di Modena | 90 | 2022-06-01 | 2025-05-20 | |
| Improvement in Glycemic Response After Bariatric Surgery sleeve gastrectomy surgery, gastric bypass surgery, control - Bariatric Surgery | Recruiting | Weizmann Institute of Science | 120 | 2021-07-01 | 2026-05-20 | |
| Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma Folfirinox, Gemcitabine, radiation therapy - Pancreas Cancer | Phase 2 | Active not recruiting | University of Cincinnati | 32 | 2021-03-17 | 2026-08-11 |
| Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers MVT-5873, pancreatectomy or hepatectomy - Colon Cancer, Pancreatic Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 10 | 2019-11-13 | 2023-03-21 |
| Energy Expenditure and Nutrition After Pancreatic Surgery Pancreatectomy, Indirect calorimetry - Whipple Procedures, Pancreatic Cancer | Recruiting | Evangelismos Hospital | 150 | 2017-01-10 | 2026-07-14 | |
| Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer Patients will receive initial chemotherapy, followed by evaluation of the response to the treatment, followed by SBRT, followed by chemotherapy. - Cancer of Pancreas, Unresectable Pancreatic Cancer | Phase 2 | Completed | Medical University of Silesia | 40 | 2017-01-01 | 2019-11-13 |
| WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer Pancreatectomy, Lavage - Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma | Not applicable | Active not recruiting | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 845 | 2016-04-27 | 2026-05-29 |
| S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Fluorouracil, Gemcitabine Hydrochloride, Irinotecan Hydrochloride - Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma | Phase 2 | Completed | SWOG Cancer Research Network | 147 | 2016-01-06 | 2022-10-19 |
| Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease pancreatectomy - Pancreatic Neoplasms | Enrolling by invitation | National Taiwan University Hospital | 100 | 2016-01-01 | 2026-02-27 | |
| Endocrine-exocrine Functions and Prognosis After Pancreatectomy pancreatectomy - Pancreatic Neoplasm | Recruiting | National Taiwan University Hospital | 3500 | 2016-01-01 | 2026-02-09 | |
| Delayed Gastric Emptying After Pancreatic Surgery pancreatectomy - Pancreatic Neoplasm | Recruiting | National Taiwan University Hospital | 3500 | 2016-01-01 | 2026-02-03 | |
| Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival pancreatectomy - Pancreatic Neuroendocrine Tumor | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 2 | 2015-12-01 | 2015-12-08 | |
| Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail Celiac plexus resection, Pancreatectomy - Pancreatic Cancer | Phase 3 | Unknown | Fudan University | 180 | 2014-01-01 | 2016-08-11 |
Showing 20 of 25. Sign in to see all of them.
Pancreatic Neoplasms (15) · Cholangiocarcinoma (2) · Neoplasm Metastasis (2) · Pancreatitis (2) · Adenoma, Islet Cell (1) · Carcinoma, Acinar Cell (1) · Colonic Neoplasms (1) · Gastroparesis (1) · Hyperamylasemia (1) · Kidney Failure, Chronic (1) · Neoplasms (1) · Pancreatic Intraductal Neoplasms (1) · Pancreatitis, Chronic (1) · Peritoneal Neoplasms (1)
National Taiwan University Hospital (3) · National Cheng-Kung University Hospital (2) · Azienda Ospedaliero-Universitaria di Modena (1) · Evangelismos Hospital (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · Florida Hospital Tampa Bay Division (1) · Fudan University (1) · Icahn School of Medicine at Mount Sinai (1) · Jonsson Comprehensive Cancer Center (1) · Medical University of Silesia (1) · National Cancer Institute (NCI) (1) · OHSU Knight Cancer Institute (1) · Oslo University Hospital (1) · SWOG Cancer Research Network (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (9) · Taiwan (4) · China (2) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Norway (1) · Poland (1) · Portugal (1)
Alexander Rosemurgy, MD (1) · Avner Leshem, MD (1) · Brett C Sheppard (1) · Danit Dayan, MD (1) · Davendra Sohal (1) · Davendra Sohal, Sohal (1) · Deirdre Cohen, MD (1) · Edward Livingston, MD (1) · Harish Lavu, MD (1) · Jonathan M Hernandez, M.D. (1) · Kalliopi Anna Poulia, PhD (1) · Kristin E. Anderson, Ph.D. (1) · Marius Distler, Prof. Dr. (1) · Melina Dimitriou, PhD (1) · Michael Nicholl, MD (1)
PMID 16878410, PMID 17879305, PMID 21844506, PMID 22750974, PMID 26038044, PMID 28396721, PMID 32399263, PMID 32740235, PMID 33475684, PMID 38445914, PMID 9548661
U10CA180888 (1)